Literature DB >> 2169192

Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.

W Bondareff1, C M Wischik, M Novak, W B Amos, A Klug, M Roth.   

Abstract

Antibodies directed against three regions of tau, ubiquitin, and B-amyloid were used in a histologic study of neurofibrillary degeneration in Alzheimer's disease to distinguish two populations of neurofibrillary tangles. Intracellular tangles were immunolabeled exclusively by two antibodies raised against antigens in the fuzzy coat of the paired helical filament (PHF). Extracellular tangles were distinguished by selective immunolabeling with a monoclonal antibody raised against antigens in the PHF core. This was associated with removal of the fuzzy coat and exposure of PHF-core epitopes. In the transition from intracellular to extracellular compartments in vivo, tangles appeared to undergo changes similar to protease digestion in vitro. The transition was associated with the appearance of amyloid immunoreactivity. These findings suggest that tangle degradation occurs in a series of distinct stages, including ubiquitination of some unknown molecule, a change in tau immunoreactivity, and partial proteolysis of tangle-bound tau in extracellular tangles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169192      PMCID: PMC1877533     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease.

Authors:  G Perry; P Mulvihill; V A Fried; H T Smith; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

2.  Senile plaque amyloid, paired helical filaments, and cerebrovascular amyloid in Alzheimer's disease are all deposits of the same protein.

Authors:  M Kidd; D Allsop; M Landon
Journal:  Lancet       Date:  1985-02-02       Impact factor: 79.321

3.  Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.

Authors:  G Perry; N Rizzuto; L Autilio-Gambetti; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Alzheimer neurofibrillary tangles: monoclonal antibodies to inherent antigen(s).

Authors:  G P Wang; I Grundke-Iqbal; R J Kascsak; K Iqbal; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

5.  Aberrant neurofilament phosphorylation in Alzheimer disease.

Authors:  N H Sternberger; L A Sternberger; J Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.

Authors:  S C Papasozomenos
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

7.  Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.

Authors:  C Bancher; C Brunner; H Lassmann; H Budka; K Jellinger; G Wiche; F Seitelberger; I Grundke-Iqbal; K Iqbal; H M Wisniewski
Journal:  Brain Res       Date:  1989-01-16       Impact factor: 3.252

8.  Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease.

Authors:  M R Palmert; T E Golde; M L Cohen; D M Kovacs; R E Tanzi; J F Gusella; M F Usiak; L H Younkin; S G Younkin
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

9.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Authors:  C L Masters; G Multhaup; G Simms; J Pottgiesser; R N Martins; K Beyreuther
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

10.  Subunit structure of paired helical filaments in Alzheimer's disease.

Authors:  C M Wischik; R A Crowther; M Stewart; M Roth
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

View more
  36 in total

1.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Evidence that neurofibrillary tangles undergo glial modification.

Authors:  K Ikeda; H Akiyama; C Haga; S Haga
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.

Authors:  D W Dickson; H Ksiezak-Reding; W K Liu; P Davies; A Crowe; S H Yen
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.

Authors:  M A Wrzolek; P A Merz; R Kascsak; I Grundke-Iqbal; K Iqbal; R Rubenstein; M Tonna-DeMasi; N L Goller; P Mehta; H M Wisniewski
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

5.  Lack of ubiquitin immunoreactivities at both ends of neuropil threads. Possible bidirectional growth of neuropil threads.

Authors:  T Iwatsubo; M Hasegawa; Y Esaki; Y Ihara
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.

Authors:  A Crowe; H Ksiezak-Reding; W K Liu; D W Dickson; S H Yen
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

7.  Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.

Authors:  G Perry; P Cras; S L Siedlak; M Tabaton; M Kawai
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

8.  The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.

Authors:  Jerzy Wegiel; Karol Dowjat; Wojciech Kaczmarski; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur Kolecka; Jarek Wegiel; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Cheng-Xin Gong; Fei Liu; Tatyana Adayev; Mo-Chou Chen-Hwang; Yu-Wen Hwang
Journal:  Acta Neuropathol       Date:  2008-08-12       Impact factor: 17.088

9.  Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease.

Authors:  C R Harrington; E B Mukaetova-Ladinska; R Hills; P C Edwards; E Montejo de Garcini; M Novak; C M Wischik
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

10.  Monitoring pathological assembly of tau and beta-amyloid proteins in Alzheimer's disease.

Authors:  R Mena; P Edwards; O Pérez-Olvera; C M Wischik
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.